Equity in Autism Diagnosis and Treatment: What will it Take?
Dr. Sarabeth Broder-Fingert, MD, MPH will present, Equity in Autism Diagnosis and Treatment: What will it Take?, and will discuss the history of autism diagnosis and ongoing efforts to improve the diagnostic process and treatment as evaluated through a health equity lens. This is the first installment of the FPG Distinguished Speaker Series. The series theme is “Examining Equity and Diversity in the Field of Developmental Disabilities.”
Dr. Broder-Fingert is a pediatrician an implementation scientist who focuses on developing, testing, implementing, and disseminating novel interventions to improve access to diagnostic and treatment services for autistic youth. She specifically focuses on ensuring all children have access to services, particularly those from minoritized populations. She is PI or Co-I on multiple NIMH-funded studies to evaluate implementation of innovations to improve access to services for children with ASD. Dr. Broder-Fingert serves as Vice Chair for Clinical Research for the Department of Pediatrics at UMASS Medical School and Associate Director for Research at the Eunice Kennedy Shriver Center at UMASS. She serves as implementation lead on a number of NIH, federally, and privately funded projects, and serves as an expert consultant for the National Academies of Sciences, Engineering, and Medicine, Zero-to-Three, and the Patient Centered Outcomes Research Institute.